Related Experiment Video

Updated: Jul 6, 2026

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein
08:26

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein

Published on: June 12, 2018

Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a

Yasuko Kondo1, Seiji Kondo

  • 1Department of Neurosurgery, Anderson Cancer Center, Houston, TX, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2008
PubMed

Insights

This study introduces a novel 2-5A antisense system targeting human telomerase RNA (hTR) to inhibit cancer cell growth. The developed 2-5A-anti-hTR demonstrated significant antitumor effects in vitro and in vivo.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Telomerase is a key enzyme in most cancers, including malignant gliomas, but absent in normal cells.
  • Targeting telomerase offers a promising strategy for cancer therapy.

Purpose of the Study:

  • To develop and evaluate a novel therapeutic approach using the 2',5'-oligoadenylate (2-5A) antisense system to inhibit telomerase.
  • To assess the antitumor efficacy of a synthesized 2-5A linked to an antisense oligonucleotide against human telomerase RNA (hTR) in cancer cells.

Main Methods:

  • Synthesis of a 2-5A-conjugated antisense oligonucleotide targeting hTR (2-5A-anti-hTR).
  • Evaluation of the compound's efficacy against telomerase-positive cancer cells in vitro and in vivo.
  • Utilizing the 2-5A system to activate RNase L for specific RNA degradation.

Main Results:

  • The synthesized 2-5A-anti-hTR effectively inhibited telomerase activity in cancer cells.
  • Demonstrated significant antitumor effects of 2-5A-anti-hTR on telomerase-positive cancer cells both in vitro and in vivo.

Conclusions:

  • The 2-5A antisense system is a potent strategy for targeting telomerase in cancer therapy.
  • 2-5A-anti-hTR shows promise as a novel therapeutic agent for treating telomerase-dependent cancers.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...